ENTX vs UTHR · $58.2M cap vs P/E 20, rev $1.56B
Entera Bio Ltd (ENTX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ENTX currently screens at market cap $58.2M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ENTX and UTHR stock pages for the full models.
Not investment advice.